Patellofemoral Pain SyndromeNCT04340453
The Comparison of Hip and Knee Focused Exercises Versus Hip and Knee Focused Exercises With the Use of Blood Flow Restriction Training in Adults With Patellofemoral Pain
A study testing Exercise with Blood Flow restriction training, Hip and Knee Exercise Program and stretching in people with Patellofemoral Pain Syndrome, run by European University Cyprus at 1 site in Cyprus.
Trial summary
Hip and Knee strengthening exercises are implemented in Patellofemoral Pain (PFP) rehabilitation but exercising in high loads to achieve muscle changes in strength may lead to increased patellofemoral joint stress. Read more about this study
- Who is it for?
- Ages 18 to 40 years
- Conditions the study is for
- Patellofemoral Pain Syndrome
- What is being tested?
- Exercise with Blood Flow restriction training, Hip and Knee Exercise Program and stretching
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteCyprus
- Study dates
- 29 Nov 2019to 29 Feb 2020
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 40 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Volunteers to be included can be either male or female, must be 18-40 years of age and should have at least a 4 week, history of peri or retro-patella non traumatic pain, with intensity of worst pain during the previous week at 3cm on the Visual Analogue Scale (VAS).
- Pain should be aggravated by at least two of the following functional tasks: squatting, kneeling, prolonged sitting, stair ascending or descending, hopping or running.
- During physical examination pain must be present with either palpation of the patella facets or with the patella compression test or a deep squat.
- Volunteers with bilateral symptoms will be documented but the limb with the worst pain will be used for analysis.
Who cannot join
- Athletes will be excluded, as well as participants with a high level of physical activity based on assessment of the International Physical Activity Questionnaire (IPAQ) in Greek. This will be performed on the day of initial screening. Their exclusion is based on the fact that they may not respond to the level of intensity of the exercises provided in this study and for homogeneity of the sample.
- Volunteers with the following characteristics will also be excluded:
- History or current meniscus ligament or other knee injury and/or surgery.
- Other knee pathology such as knee osteoarthritis, Osgood- Schlatter or Sinding-Larsen-Johanssen syndrome or tendinopathy of muscles surrounding the knee. Knee instability, feeling of "giving way", history of subluxation or dislocation of the knee joint or joint edema.
- Extended use of NSAID or cortisone.
- Referred pain from lumbar spine or another region.
Show all 14Show fewer
- Patella dysplasia, rheumatoid arthritis or neurological syndromes or diseases
- During clinical examination volunteers with pain located on the patella tendon that is eliminated with isometric contraction, the pes anserinus, the Iliotibial Band (ITB), or with a positive medial or lateral patella apprehension test will also be excluded
- Volunteers that had previous treatment for PFP in the past 6 months will also be excluded to avoid non responders and carryover effects from previous treatments.
- Volunteers with unexplained chest pains
- Cardiovascular disease, renal disease, vascular surgery or disease
- Deep Venous Thrombosis (DVT) or high risk for DVT, resent surgery ≤6 months, - High blood pressure (≥140/90mmHg) dizzy spells, history of fainting or dizziness with exercise
- Pregnancy
- Any contraindication to exercise
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Comparison of Hip and Knee Focused Exercises Versus Hip and Knee Focused Exercises With the Use of Blood Flow Restriction Training in Adults With Patellofemoral Pain: A Randomized Controlled Trial.
Hip and Knee strengthening exercises are implemented in Patellofemoral Pain (PFP) rehabilitation but exercising in high loads to achieve muscle changes in strength may lead to increased patellofemoral joint stress. Low load training with Blood Flow Restriction (BFR) may allow for exercise strength benefits to proximal and distal muscles with reduced joint stress and by promoting hypoalgesia.
The purpose of this study is to compare hip and knee focused exercises with and without BFR training in adults with PFP. The main outcome of this study is function ability which will be measured with the Kujala Anterior Knee pain Scale translated in the Greek language at four weeks post intervention and at two months follow up. Our null hypothesis is that there will be no difference between groups for primary and secondary outcomes measured at four weeks and two months post intervention.
Read the detailed description
This a randomized controlled clinical trial with first primary end point at four weeks and second primary end point at two months.
Sample size was determined through power analysis. The Minimal Clinically Significant Difference (MCID) of our main outcome measure, Kujala Anterior Knee Pain Scale, was used for the estimation. The MCID of the Kujala scale has been reported to be 10 points with an estimated standard deviation of 13,5 points. For a power of 0.80 and a level of significance a=0.05 and considering a two tailed t-test the sample size was calculated to be 60 participants total (30 in each group). The GPower 3.0.10 software was used to calculate the sample size. By estimating a possible 20% drop out we concluded to a sample size of 75.
The participants of this study will be volunteers and considered a sample of convenience since no official records or data base exists in Cyprus with all PFP patients. Participant recruitment will begin in November 2019. Potential participants will be informed for the study through printed posters around the European University Cyprus (EUC) campus, local social media online posters and will volunteer for inclusion. Screening will be carried out by an orthopedic surgeon, at the musculoskeletal laboratory of the EUC to determine their eligibility based on specific inclusion and exclusion criteria.
Volunteers who meet inclusion criteria will receive oral and written information and give informed consent to participate in the study by signing a consent form. They will be randomized into one of two treatment groups. Group 1 will be the Hip and Knee Exercise group and Group 2 the BFR training Hip and Κnee exercise group. Randomization will be carried out using a block sequence of 4 by an external statistician to maintain a balance in sample size across groups over time and to ensure the assessor was blind to the participants allocation.
All interventions will take place in the musculoskeletal laboratory and the training center lab of the EUC. Time consistency in treatments will be a goal, in order to train participants at similar circadian rhythm. Room temperature for both labs will be set at 25 °C. Two experienced physiotherapists will each be randomly assigned to supervise one of the two intervention groups and provide the treatment. The therapists role is to supervise treatments and their progression, keep track of compliance with the study design, adverse effects and drop outs. If patients do not comply with the study (seek other treatment for PFP, exercise during the study, inability to attend treatments) design they will be excluded. The two therapist will be blinded as to the other groups treatment protocol and the studies outcomes. They will be given written information for all procedures of their intervention group in order to ensure consistency throughout the study. Data collected by the therapists will be stored at the E.U.C laboratories and will only be available to them. Additionally, the therapists will be assisted by fourth year physiotherapy undergraduate students in supervising participants during treatments. Participants who fail to complete at least 10/12 therapy sessions will be excluded and their data will not be analyzed. All therapy sessions will be supervise by a physician who will be in charge of participants safety. Any adverse events will be reported with publication of final results. Participants are free to withdraw from the study at any given moment. In case of any complaints, participants have the right to file official complaints to the university bioethics committee.
Planed statistical analysis: Statistical analysis will be performed by the studies assessor who is blinded to the participants treatment group using the IBM SPSS "Statistical Package for the Social Sciences" (SPSS, Version 20.0). Descriptive statistics will be analyzed with the calculation of means, standard deviations, minimum and max values for each variable. A normality check will follow using the One Sample Kolmogorov-Smirnov test (p<0.05). The chi-squared test will be used to test for difference between the two groups with respect to the categorical variable gender. To check for differences within groups (baseline-4weeks, baseline-2months follow up and 4weeks-2months follow up) we will use the paired t-test for each comparison. In case of nonparametric data, the Wilcoxon signed rank test will be used. In order to estimate differences between the two groups (baseline-4weeks, baseline-2months follow up and 4weeks-2months follow up) we will use the mixed two way ANOVA with time as a within-subjects factor and treatment as the between subjects factor. Homogeneity of variance will be checked with the Levene test <0.05. In the case of not normally distributed data we will use the generalized mixed effect model with treatment as a fixed factor, time as a random factor, and inverse as the link function. Possible correlations will also be checked for our outcome measures using the Pearson correlation coefficient. In case of not normally distributed data the Spearman correlation coefficient will be used if there seems to be a linear correlation from a scatter plot. Missing values in the Patient Reported Outcome Measures will be imputed using Multiple Imputation (MI). Only upon agreement by the authors that there will be no further changes and/or analysis, results of the study will be published.
- Conditions
- Patellofemoral Pain Syndrome
- Being tested
- Exercise with Blood Flow restriction training, Hip and Knee Exercise Program, stretching
- Keywords
- Patellofemoral Pain, Exercise, Rehabilitation, Blood Flow Restriction training, physical therapy, physiotherapy
- Medical subject headings
- Patellofemoral Pain Syndrome, Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Exercise with Blood Flow restriction trainingOther
Also called BFR training
3 times a week for 4 weeks to a total of 12 sessions. BFR cuff (Sports Rehab Tourniquet©) will be used, with a width of 10cm and a length of 116cm or 84cm depending on the diameter of the participants thigh. Therapy sessions will be supervised and in groups. Exercises focus on strengthening the hip extensors and abductors, as well as the quadriceps both in open and closed kinetic chain. Exercises will be carried out using will be set at a load of 30% of 1RM with a limb occlusion pressure (LOP) of 70%. The first set will consist of 30reps. followed by 3 sets of 15reps. at 2:2 (con/ecc) at 60bpm by Metronome app. with auditory cue. Rest between sets will be 30sec and between exercises 2min. Cuffs will be deflated during the resting period between exercises and re-inflated at the beginning of the next exercise. Exercise progression will be individualized based on assessments at the beginning of each week. The duration has been estimated to be approximately 60min. including LOP estimation.
Hip and Knee Exercise ProgramOther
Also called Standard treatment
A supervised hip and knee strengthening exercise protocol with a combination of stretching, 3 times a week for 4 weeks to a total of 12 sessions. Exercises focus on hip extensors, abductors, as well as the quadriceps and hamstrings strength. Open Kinetic Chain (OKC) exercises will be executed first followed by CKC exercises. Exercises using weights or mechanical resistance will be set at a load of 70% of 1RM and 3 sets of 10 rep. for each exercise. Elastic band exercises will be set at 10RM for 3 sets. Tempo will be set by the Metronome app installed on a Smartphone at 1:2 (con/ecc) at 60bpm with auditory cue. Rest between sets will be 30sec and between exercises 2min. Exercise progression will be individualized based on assessments at the beginning of each week. The duration of each session is estimated to be approximately 45min, with the exception of the first session of each week which is estimated to be 80min due to the addition of strength testing
stretchingOther
Both groups will receive stretching of the hamstrings, plantar flexors, quadriceps and Iliotibial Band (ITB) in the same manor at the end of each session. Passive stretching will be executed by the physiotherapist with 3x30sec stretch for each muscle group
| Study group | Role | What they receive |
|---|---|---|
| Group 1 (Hip and Knee Exercise Program) | Active comparator | Standard exercise physiotherapy treatment of a Hip and Knee Exercise Program plus stretching. Receives: Other: Hip and Knee Exercise Program; Other: stretching |
| Group 2 (BFR-training hip and knee exercise group) | Experimental | BFR-training hip and knee exercise group plus stretching. Receives: Other: Exercise with Blood Flow restriction training; Other: stretching |
What is being measured
The primary outcome is the main question the study is designed to answer.
"change" is being assessed for Function The Greek version of the Kujala Anterior Knee Pain Scale (AKPS)
The AKPS is a 13-item questionnaire that documents response to six different activities such as walking, running, jumping, stair climbing, squatting and prolonged sitting with knee bent, as well as patients symptoms, such as limping, inability to weight bear on the affected limb, swelling, abnormal patella movement, muscle atrophy and limitations of flexion of knee joint. The AKPS asks about the duration of symptoms and limb(s) affected. The maximum score is 100 (no pain/disability/limitation) and the minimum 0 (worst possible function). This questionnaire has been previously used in PFP studies and is found to be a valid and reliable measure for PFP patients with a minimally clinical significant difference (MCID) of 10points. The Greek version has been found to have good internal consistency (Cronbach's a=0.942), test-retest reliability (ICC=0.921) and concurrent validity (r>0.7)
Measured: baseline, 4 weeks (end of treatment), 2 months (follow up)
Secondary outcomes (6)
"change" is being assessed. Pain with the Visual Analog Scale
Pain will be assessed using the visual analog scale VAS 0-10cm. This scale is a 10cm horizontal line with two small vertical lines at the two ends. The far-left side is 0 "no pain" and the far right is 10 "worst pain". Participants will be asked to mark with a horizontal line to rate the level of worst pain VAS-W and the level of their usual pain VAS-U that they experienced during the course of the previous week. A standard ruler will be used to measure the distance from 0 to the participants mark. The VAS scale measuring these two types of pain have been shown to be valid and reliable in patients with PFP with an MCID of 2cm.
Measured: baseline, 4 weeks (end of treatment), 2 months (follow up)
"change" is being assessed. Pain with single leg squatting (shallow-deep)
Two depths of squatting will be assessed and the VAS scale will be used to quantify the level of pain with each squat. For the first Single-leg squat (shallow): the participant will stand in front of the treatment bed and the height of the bed will be adjusted to be the mid-point of his thigh (halfway between the greater trochanter and popliteal fossa midpoint). For the second Single-leg squat (deep): the beds height will be adjusted to the popliteal fossa midpoint. Participants will perform the squat with hands crossed over the chest until they touch but not sit on the beds surface. At the end of each test, the VAS scale will be used to measure pain felt during the squat. This testing method has been previously used to assess pain in anterior knee pain patients.
Measured: baseline, 4 weeks (end of treatment), 2 months (follow up)
"change" is being assessed. Kinesiophobia: The Tampa scale of Kinesiophobia (TSK)
We will assess Kinesiophobia using the Greek Version of the TSK that has been found to be valid and reliable. This scale consists of 17 items that assess fear of injury due to movement. Participants will be asked to make ratings of their degree of agreement for each of the 17 items. Ratings range from 1 (strongly disagree) to 4 (strongly agree). Responses will be summed after reversing the scores of items 4,8,12 and 16. Higher total scores relate to higher related fear.
Measured: baseline, 4 weeks (end of treatment), 2 months (follow up)
"change" is being assessed. Catastrophizing: The Pain Catastrophizing Scale (PCS)
The Pain Catastrophizing Scale (PCS) assesses the cognitive process by which pain is seen as an extreme threat and from which the patient suffers exaggerated negative consequences. We will assess catastrophizing using the Greek Version of the PCS that has been found to be valid and reliable. The questionnaire consists of 13 items (statements) describing pain experience and participants are asked to indicate whether they agree with these statements on a five point scale rating from 0 (not at all) to 4 (always). Scores are summed to calculate a final score. A high score indicates a high level of pain catastrophizing. The PSC measures three categories: rumination, magnification and helplessness. Rumination refers to the patients' inability to apart the pain from his mind, magnification expresses the exaggerated cognitions of pain as a threat, and hopelessness is the estimation that the patient cannot do anything to influence his pain.
Measured: baseline, 4 weeks (end of treatment), 2 months (follow up)
"change" is being assessed. Maximum pain free flexion angle using the decline step down test
This is a functional test that measures the Maximum Pain Free Flexion Angle (MPFFA) of the knee joint whilst descending a 20cm high step with a surface inclination of 20o. The participant descends from the step to the maximum point where no pain is present. At this point the assessor will take a photo using the Dr. Goniometer (DrG) app, installed on an iPhone 6S andmeasure the MPFFA. The test has been found to be reliable with intra-observer reliability ICC=0.83 and inter-observer reliability ICC=0.85. It has been shown to be valid as it has been correlated with the AKPS (r= 0.31, p= 0.030
Measured: baseline, 4 weeks (end of treatment), 2 months (follow up)
"change" is being assessed. Strength: Strength tests will measure isometric Maximum Voluntary Contraction (MVIC) with the use of a MicroFET2TM Hand Held Dynamometer (HHD).
Strength tests will measure isometric Maximum Voluntary Contraction (MVIC) with the use of a MicroFET2TM Hand Held Dynamometer (HHD) for the quadriceps at ≈60o of knee flexion from the seated position. Hip extensors will be assessed from the prone position and hip abductors in the side-lying position with the hip abducted to ≈10o. Strength will be recorded in Newtons (N). Testing will begin after 2-3 sub-maximal contractions for familiarization and warm up followed by a maximal isometric contraction of a 5sec duration with standard verbal encouragement by the assessor. then followed by a 30sec rest and then repeated. If the two measures differ less than 10% then no other testing will follow. The mean of the two measures will be used for analysis. If measures differ >10%, a third test will be repeated until the above criteria is met. Placement of the dynamometer will be marked with a marker to ensure consistency between trials.
Measured: baseline, 4 weeks (end of treatment), 2 months (follow up)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Apr 2020
- Study start29 Nov 2019
- Primary completion21 Dec 2019
- Study completion29 Feb 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Patellofemoral Pain SyndromeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- This a randomized controlled trial with first primary end point at four weeks and second primary end point at two months. Participants will be allocated randomly into one of two intervention groups. Group1 (Knee and hip focused exercises) Group 2 (knee and hip focused exercises with BFR)
- Masking
- Double blind
- Who is masked
- Investigator, Outcomes assessor
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- European University Cyprus
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Antonis Constantinou, European University Cyprus
- Investigators
- Antonis Constantinou, PhDcan, Principal investigator, European University CyprusDimitris Stasinopoulos, PhD, Study director, European University Cyprus
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04340453
- Sponsor's protocol ID
- ΕΕΒΚ/ΕΠ/2019/86
- Status last verified
- Apr 2020
- First submitted
- 6 Apr 2020
- Last updated
- 9 Apr 2020
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Only upon agreement by the authors that there will be no further changes and/or analysis, results of the study will be published and shared. No patient data will be shared to be compliant with the latest GDPR code.
Study at a glance
From the registry record, last updated by the sponsor on 9 Apr 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Comparison of Hip and Knee Focused Exercises Versus Hip and Knee Focused Exercises With the Use of Blood Flow Restriction Training in Adults With Patellofemoral Pain: A Randomized Controlled Trial.
- ClinicalTrials.gov ID
- NCT04340453
- Acronym / sponsor ID
- ΕΕΒΚ/ΕΠ/2019/86
- Conditions
- Patellofemoral Pain Syndrome
- Keywords
- Patellofemoral Pain, Exercise, Rehabilitation, Blood Flow Restriction training, physical therapy, physiotherapy
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- European University CyprusUniversity, hospital or other
- Study start
- 29 Nov 2019 (actual)
- Primary completion
- 21 Dec 2019 (actual)
- Study completion
- 29 Feb 2020 (actual)
- First posted
- 9 Apr 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Hip and Knee strengthening exercises are implemented in Patellofemoral Pain (PFP) rehabilitation but exercising in high loads to achieve muscle changes in strength may lead to increased patellofemoral joint stress. Low load training with Blood Flow Restriction (BFR) may allow for exercise strength benefits to proximal and distal muscles with reduced joint stress and by promoting hypoalgesia.
The purpose of this study is to compare hip and knee focused exercises with and without BFR training in adults with PFP. The main outcome of this study is function ability which will be measured with the Kujala Anterior Knee pain Scale translated in the Greek language at four weeks post intervention and at two months follow up. Our null hypothesis is that there will be no difference between groups for primary and secondary outcomes measured at four weeks and two months post intervention.
Detailed description
This a randomized controlled clinical trial with first primary end point at four weeks and second primary end point at two months.
Sample size was determined through power analysis. The Minimal Clinically Significant Difference (MCID) of our main outcome measure, Kujala Anterior Knee Pain Scale, was used for the estimation. The MCID of the Kujala scale has been reported to be 10 points with an estimated standard deviation of 13,5 points. For a power of 0.80 and a level of significance a=0.05 and considering a two tailed t-test the sample size was calculated to be 60 participants total (30 in each group). The GPower 3.0.10 software was used to calculate the sample size. By estimating a possible 20% drop out we concluded to a sample size of 75.
The participants of this study will be volunteers and considered a sample of convenience since no official records or data base exists in Cyprus with all PFP patients. Participant recruitment will begin in November 2019. Potential participants will be informed for the study through printed posters around the European University Cyprus (EUC) campus, local social media online posters and will volunteer for inclusion. Screening will be carried out by an orthopedic surgeon, at the musculoskeletal laboratory of the EUC to determine their eligibility based on specific inclusion and exclusion criteria.
Volunteers who meet inclusion criteria will receive oral and written information and give informed consent to participate in the study by signing a consent form. They will be randomized into one of two treatment groups. Group 1 will be the Hip and Knee Exercise group and Group 2 the BFR training Hip and Κnee exercise group. Randomization will be carried out using a block sequence of 4 by an external statistician to maintain a balance in sample size across groups over time and to ensure the assessor was blind to the participants allocation.
All interventions will take place in the musculoskeletal laboratory and the training center lab of the EUC. Time consistency in treatments will be a goal, in order to train participants at similar circadian rhythm. Room temperature for both labs will be set at 25 °C. Two experienced physiotherapists will each be randomly assigned to supervise one of the two intervention groups and provide the treatment. The therapists role is to supervise treatments and their progression, keep track of compliance with the study design, adverse effects and drop outs. If patients do not comply with the study (seek other treatment for PFP, exercise during the study, inability to attend treatments) design they will be excluded. The two therapist will be blinded as to the other groups treatment protocol and the studies outcomes. They will be given written information for all procedures of their intervention group in order to ensure consistency throughout the study. Data collected by the therapists will be stored at the E.U.C laboratories and will only be available to them. Additionally, the therapists will be assisted by fourth year physiotherapy undergraduate students in supervising participants during treatments. Participants who fail to complete at least 10/12 therapy sessions will be excluded and their data will not be analyzed. All therapy sessions will be supervise by a physician who will be in charge of participants safety. Any adverse events will be reported with publication of final results. Participants are free to withdraw from the study at any given moment. In case of any complaints, participants have the right to file official complaints to the university bioethics committee.
Planed statistical analysis: Statistical analysis will be performed by the studies assessor who is blinded to the participants treatment group using the IBM SPSS "Statistical Package for the Social Sciences" (SPSS, Version 20.0). Descriptive statistics will be analyzed with the calculation of means, standard deviations, minimum and max values for each variable. A normality check will follow using the One Sample Kolmogorov-Smirnov test (p<0.05). The chi-squared test will be used to test for difference between the two groups with respect to the categorical variable gender. To check for differences within groups (baseline-4weeks, baseline-2months follow up and 4weeks-2months follow up) we will use the paired t-test for each comparison. In case of nonparametric data, the Wilcoxon signed rank test will be used. In order to estimate differences between the two groups (baseline-4weeks, baseline-2months follow up and 4weeks-2months follow up) we will use the mixed two way ANOVA with time as a within-subjects factor and treatment as the between subjects factor. Homogeneity of variance will be checked with the Levene test <0.05. In the case of not normally distributed data we will use the generalized mixed effect model with treatment as a fixed factor, time as a random factor, and inverse as the link function. Possible correlations will also be checked for our outcome measures using the Pearson correlation coefficient. In case of not normally distributed data the Spearman correlation coefficient will be used if there seems to be a linear correlation from a scatter plot. Missing values in the Patient Reported Outcome Measures will be imputed using Multiple Imputation (MI). Only upon agreement by the authors that there will be no further changes and/or analysis, results of the study will be published.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (investigator, outcomes assessor)
- Number of arms
- 2
- Model description
- This a randomized controlled trial with first primary end point at four weeks and second primary end point at two months. Participants will be allocated randomly into one of two intervention groups. Group1 (Knee and hip focused exercises) Group 2 (knee and hip focused exercises with BFR)
| Arm | Type | Receives |
|---|---|---|
| Group 1 (Hip and Knee Exercise Program) | Active comparator | Other: Hip and Knee Exercise Program, Other: stretchingStandard exercise physiotherapy treatment of a Hip and Knee Exercise Program plus stretching. |
| Group 2 (BFR-training hip and knee exercise group) | Experimental | Other: Exercise with Blood Flow restriction training, Other: stretchingBFR-training hip and knee exercise group plus stretching. |
Who may qualify
- Ages
- 18 to 40 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- Volunteers to be included can be either male or female, must be 18-40 years of age and should have at least a 4 week, history of peri or retro-patella non traumatic pain, with intensity of worst pain during the previous week at 3cm on the Visual Analogue Scale (VAS).
- Pain should be aggravated by at least two of the following functional tasks: squatting, kneeling, prolonged sitting, stair ascending or descending, hopping or running.
- During physical examination pain must be present with either palpation of the patella facets or with the patella compression test or a deep squat.
- Volunteers with bilateral symptoms will be documented but the limb with the worst pain will be used for analysis.
Key exclusion criteria (14 listed)
- Athletes will be excluded, as well as participants with a high level of physical activity based on assessment of the International Physical Activity Questionnaire (IPAQ) in Greek. This will be performed on the day of initial screening. Their exclusion is based on the fact that they may not respond to the level of intensity of the exercises provided in this study and for homogeneity of the sample.
- History or current meniscus ligament or other knee injury and/or surgery.
- Other knee pathology such as knee osteoarthritis, Osgood- Schlatter or Sinding-Larsen-Johanssen syndrome or tendinopathy of muscles surrounding the knee. Knee instability, feeling of "giving way", history of subluxation or dislocation of the knee joint or joint edema.
- Extended use of NSAID or cortisone.
- Referred pain from lumbar spine or another region.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Exercise with Blood Flow restriction trainingAlso: BFR training3 times a week for 4 weeks to a total of 12 sessions. BFR cuff (Sports Rehab Tourniquet©) will be used, with a width of 10cm and a length of 116cm or 84cm depending on the diameter of the participants thigh. Therapy sessions will be supervised and in groups. Exercises focus on strengthening the hip extensors and abductors, as well as the quadriceps both in open and closed kinetic chain. Exercises will be carried out using will be set at a load of 30% of 1RM with a limb occlusion pressure (LOP) of 70%. The first set will consist of 30reps. followed by 3 sets of 15reps. at 2:2 (con/ecc) at 60bpm by Metronome app. with auditory cue. Rest between sets will be 30sec and between exercises 2min. Cuffs will be deflated during the resting period between exercises and re-inflated at the beginning of the next exercise. Exercise progression will be individualized based on assessments at the beginning of each week. The duration has been estimated to be approximately 60min. including LOP estimation. | Other | Group 2 (BFR-training hip and knee exercise group) |
| Hip and Knee Exercise ProgramAlso: Standard treatmentA supervised hip and knee strengthening exercise protocol with a combination of stretching, 3 times a week for 4 weeks to a total of 12 sessions. Exercises focus on hip extensors, abductors, as well as the quadriceps and hamstrings strength. Open Kinetic Chain (OKC) exercises will be executed first followed by CKC exercises. Exercises using weights or mechanical resistance will be set at a load of 70% of 1RM and 3 sets of 10 rep. for each exercise. Elastic band exercises will be set at 10RM for 3 sets. Tempo will be set by the Metronome app installed on a Smartphone at 1:2 (con/ecc) at 60bpm with auditory cue. Rest between sets will be 30sec and between exercises 2min. Exercise progression will be individualized based on assessments at the beginning of each week. The duration of each session is estimated to be approximately 45min, with the exception of the first session of each week which is estimated to be 80min due to the addition of strength testing | Other | Group 1 (Hip and Knee Exercise Program) |
| stretchingBoth groups will receive stretching of the hamstrings, plantar flexors, quadriceps and Iliotibial Band (ITB) in the same manor at the end of each session. Passive stretching will be executed by the physiotherapist with 3x30sec stretch for each muscle group | Other | Group 1 (Hip and Knee Exercise Program), Group 2 (BFR-training hip and knee exercise group) |
Primary outcome
"change" is being assessed for Function The Greek version of the Kujala Anterior Knee Pain Scale (AKPS)
Time frame: baseline, 4 weeks (end of treatment), 2 months (follow up)
The AKPS is a 13-item questionnaire that documents response to six different activities such as walking, running, jumping, stair climbing, squatting and prolonged sitting with knee bent, as well as patients symptoms, such as limping, inability to weight bear on the affected limb, swelling, abnormal patella movement, muscle atrophy and limitations of flexion of knee joint. The AKPS asks about the duration of symptoms and limb(s) affected. The maximum score is 100 (no pain/disability/limitation) and the minimum 0 (worst possible function). This questionnaire has been previously used in PFP studies and is found to be a valid and reliable measure for PFP patients with a minimally clinical significant difference (MCID) of 10points. The Greek version has been found to have good internal consistency (Cronbach's a=0.942), test-retest reliability (ICC=0.921) and concurrent validity (r>0.7)
6 secondary outcomes
"change" is being assessed. Pain with the Visual Analog Scale
Time frame: baseline, 4 weeks (end of treatment), 2 months (follow up)
"change" is being assessed. Pain with single leg squatting (shallow-deep)
Time frame: baseline, 4 weeks (end of treatment), 2 months (follow up)
"change" is being assessed. Kinesiophobia: The Tampa scale of Kinesiophobia (TSK)
Time frame: baseline, 4 weeks (end of treatment), 2 months (follow up)
"change" is being assessed. Catastrophizing: The Pain Catastrophizing Scale (PCS)
Time frame: baseline, 4 weeks (end of treatment), 2 months (follow up)
"change" is being assessed. Maximum pain free flexion angle using the decline step down test
Time frame: baseline, 4 weeks (end of treatment), 2 months (follow up)
"change" is being assessed. Strength: Strength tests will measure isometric Maximum Voluntary Contraction (MVIC) with the use of a MicroFET2TM Hand Held Dynamometer (HHD).
Time frame: baseline, 4 weeks (end of treatment), 2 months (follow up)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Apr 2020.
- Individual participant dataSharing planned: Yes. Only upon agreement by the authors that there will be no further changes and/or analysis, results of the study will be published and shared. No patient data will be shared to be compliant with the latest GDPR code.
Related trials for Patellofemoral Pain Syndrome
Recruiting
Effects of Telerehabilitation Versus Supervised Rehabilitation Protocol on Pain, Range of Motion and Functional Recovery in Patients With Patellofemoral Pain Syndrome.
Patello Femoral Pain Syndrome
RecruitingObservational study
MRI Study of Musculoskeletal Function
Abnormalities, Imaging
Not yet recruiting
Comparison of High-Intensity and Conventional Physical Therapy in Musculoskeletal Disorders
Low Back Pain, Radicular Syndrome
Active, not recruiting
Stabilization vs Corrective Exercise in PFP
Patellofemoral Pain Syndrome
Not yet recruiting
Effectiveness of Selected Traditional Chinese Medicine Topical Agents on Long Distance Runner Versus Exercise Therapy as Control for Patellofemoral Pain Syndrome
Patellar Femoral Syndrome, TCMO (Ng's Prescription)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Antonis Constantinou, PhDcan principal investigator
European University Cyprus
Dimitris Stasinopoulos, PhD study director
European University Cyprus
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Exercise with Blood Flow restriction training, Hip and Knee Exercise Program and stretching in people with Patellofemoral Pain Syndrome, run by European University Cyprus at 1 site in Cyprus.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Apr 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Cyprus. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
"change" is being assessed for Function The Greek version of the Kujala Anterior Knee Pain Scale (AKPS) (time frame: baseline, 4 weeks (end of treatment), 2 months (follow up)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Apr 2020.